These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 36714983)
1. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Dammann F; Raja M; Camargo JF Transpl Infect Dis; 2023 Feb; 25(1):e14022. PubMed ID: 36714983 [TBL] [Abstract][Full Text] [Related]
2. Prevention and Treatment of Monkeypox. Rizk JG; Lippi G; Henry BM; Forthal DN; Rizk Y Drugs; 2022 Jun; 82(9):957-963. PubMed ID: 35763248 [TBL] [Abstract][Full Text] [Related]
3. Emerging pharmacological strategies for treating and preventing mpox. Grosenbach DW; Russo AT; Blum ED; Hruby DE Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723 [TBL] [Abstract][Full Text] [Related]
4. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review. Kuroda N; Shimizu T; Hirano D; Ishikane M; Kataoka Y J Infect Chemother; 2023 Feb; 29(2):228-231. PubMed ID: 36283609 [TBL] [Abstract][Full Text] [Related]
5. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Shamim MA; Padhi BK; Satapathy P; Veeramachaneni SD; Chatterjee C; Tripathy S; Akhtar N; Pradhan A; Dwivedi P; Mohanty A; Rodriguez-Morales AJ; Sah R; Al-Tammemi AB; Al-Tawfiq JA; Nowrouzi-Kia B; Chattu VK Int J Infect Dis; 2023 Feb; 127():150-161. PubMed ID: 36470502 [TBL] [Abstract][Full Text] [Related]
6. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat. Hernandez LE; Jadoo A; Kirsner RS Lancet; 2022 Sep; 400(10355):e8. PubMed ID: 36088950 [No Abstract] [Full Text] [Related]
7. The use of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS. Thet AK; Kelly PJ; Kasule SN; Shah AK; Chawala A; Latif A; Chilimuri SS; Zeana CB Clin Infect Dis; 2023 May; 76(9):1671-1673. PubMed ID: 36571287 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf. De Clercq E; Jiang Y; Li G Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022 [TBL] [Abstract][Full Text] [Related]
9. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Berhanu A; Prigge JT; Silvera PM; Honeychurch KM; Hruby DE; Grosenbach DW Antimicrob Agents Chemother; 2015 Jul; 59(7):4296-300. PubMed ID: 25896687 [TBL] [Abstract][Full Text] [Related]
10. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. Viguier C; de Kermel T; Boumaza X; Benmedjahed NS; Izopet J; Pasquier C; Delobel P; Mansuy JM; Martin-Blondel G Int J Infect Dis; 2022 Dec; 125():135-137. PubMed ID: 36397606 [TBL] [Abstract][Full Text] [Related]
11. Repurposing of the antibiotic nitroxoline for the treatment of mpox. Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017 [TBL] [Abstract][Full Text] [Related]
12. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. Desai AN; Thompson GR; Neumeister SM; Arutyunova AM; Trigg K; Cohen SH JAMA; 2022 Oct; 328(13):1348-1350. PubMed ID: 35994281 [TBL] [Abstract][Full Text] [Related]
13. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. DeLaurentis CE; Kiser J; Zucker J Antimicrob Agents Chemother; 2022 Dec; 66(12):e0122622. PubMed ID: 36374026 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital. Mondi A; Gagliardini R; Mazzotta V; Vita S; Carletti F; Pinnetti C; Giancola ML; Specchiarello E; Lanini S; Faraglia F; Minosse C; Paulicelli J; Mariano A; Rozera G; Fontana C; Faccendini P; Maggi F; Girardi E; Vaia F; Nicastri E; Antinori A J Infect; 2023 Jan; 86(1):66-117. PubMed ID: 36347428 [No Abstract] [Full Text] [Related]
15. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. Hung YP; Lee CC; Lee JC; Chiu CW; Hsueh PR; Ko WC J Microbiol Immunol Infect; 2022 Oct; 55(5):795-802. PubMed ID: 36115792 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans. Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888 [TBL] [Abstract][Full Text] [Related]
17. Tecovirimat Resistance in Mpox Patients, United States, 2022-2023. Smith TG; Gigante CM; Wynn NT; Matheny A; Davidson W; Yang Y; Condori RE; O'Connell K; Kovar L; Williams TL; Yu YC; Petersen BW; Baird N; Lowe D; Li Y; Satheshkumar PS; Hutson CL Emerg Infect Dis; 2023 Dec; 29(12):2426-2432. PubMed ID: 37856204 [TBL] [Abstract][Full Text] [Related]
18. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Siegrist EA; Sassine J Clin Infect Dis; 2023 Jan; 76(1):155-164. PubMed ID: 35904001 [TBL] [Abstract][Full Text] [Related]
19. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. Sherwat A; Brooks JT; Birnkrant D; Kim P N Engl J Med; 2022 Aug; 387(7):579-581. PubMed ID: 35921403 [No Abstract] [Full Text] [Related]
20. Clinical considerations on monkeypox antiviral medications: An overview. Pourkarim F; Entezari-Maleki T Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]